Description
Individuals with a history of cancer, diabetes, or those predisposed to hypoglycemia should avoid using IGF-1 LR3 due to the increased risk of adverse effects. Pregnant or breastfeeding women should also refrain from its use, as the impacts on fetal development or infants are not well understood.
<ol> <li>Peptide</li> <li>Muscle recovery</li> <li>Muscle growth</li> </ol>